Key facts
- This page summarizes Samuel D. Tweardy's Form 4 filing for Tvardi Therapeutics, Inc. (TVRD).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Aug 2025, 20:03.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Other
Other
No transaction description listed
Additional SEC filing notes
Section 16 status
Samuel D. Tweardy is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Footnote F1
The Reporting Person resigned as trustee of the family trust that directly holds the shares, as such the Reporting Person no longer retains any form beneficial ownership. The resignation does not constitute a sale of the of the shares and was permitted by the lock-up agreement by and between each family trust and the Issuer, dated December 17, 2024, and the shares remain subject to the lock-up agreement pursuant to the terms thereof.
Footnote F2
Securities are directly held by a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.